IJCM  Vol.4 No.12 , December 2013
Short Term Prognostic Utility of Tc-99m DMSA Renal Imaging in Sepsis Induced Acute Renal Failure; Provisional Data
ABSTRACT

Background: Sound prognostic data in sepsis induced acute renal failure (SARF) are lacking especially on the short term outcome [STO] in the intensive care unit [ICU]. We addressed the use of Tc-99m DMSA [2,3-dimercaptosuccinicacid] renal cortical imaging as a prognostic tool in SARF. Methods: Forty patients with acute renal failure due to sepsis [age range 15-74 years; median 44.5] were subjected for full history taking complete physical examination, routine ICU monitoring, routine laboratory investigations, APACHE II [Acute Physiology and Chronic Health Evaluation] and SOFA [Sequential Organ Failure Assessment] together with Tc-99m DMSA cortical renal scintigraphy. Patients’ death in the ICU or discharge was considered as the end point of the study representing the so-called short term outcome [STO]. Results: 25% mortality rate [10/40] was found along the admission period in the ICU. All non-survivors were abnormal with DMSA imaging [NPV & PPV 100% & 66.7% respectively]. Abnormal DMSA cases showed significant positive associations with serum creatinine at admission [r = 0.5; P 0.02]; admission duration [r = 0.4; P 0.002]; APACHE II score [r = 0.5; P 0.004] and STO [r = 0.4; P 0.03]. Statistically significant difference was elicited between subjects with normal and abnormal DMSA regarding the same parameters. Conclusion: This preliminary data could raise Tc-99m DMSA renal imaging as a prognostic tool in SARF that could allow influential interference to prohibit dramatic outcomes as mortality.


Cite this paper
A. Amin, H. Nasr, G. Younis and H. Gamal, "Short Term Prognostic Utility of Tc-99m DMSA Renal Imaging in Sepsis Induced Acute Renal Failure; Provisional Data," International Journal of Clinical Medicine, Vol. 4 No. 12, 2013, pp. 543-547. doi: 10.4236/ijcm.2013.412094.
References
[1]   A. R. Nissenson, “Acute Renal Failure: Definition and Pathogenesis,” Kidney International Supplements, Vol. 66, 1998, pp. S7-S10.

[2]   G. J. Prescott, W. Metcalfe, J. Baharani, I. H. Khan, K. Simpson, W. C. Smith, et al., “A Prospective National Study of Acute Renal Failure Treated with RRT: Incidence, Aetiology and Outcomes,” Nephrology Dialysis Transplantation, Vol. 22, No. 9, 2007, pp. 2513-2519.
http://dx.doi.org/10.1093/ndt/gfm264

[3]   P. F. Sharp, H. G. Gemmell and A. D. Murray, “Practical Nuclear Medicine Third Edition Chapter,” the Urinary Tract Philip S. Cosgriff, Springer, 2006, pp. 210-224.

[4]   A. Taylor Jr., F. Akiya and M. C. Gregory, “Failure to Visualize Acutely Injured Kidneys with Technetium-99m DMSA Does Not Preclude Recoverable Function,” Journal of Nuclear Medicine, Vol. 27, No. 3, 1986, pp. 377-379.

[5]   W. Shelfhout, M. Simons, W. Oosterlink and W. A. De Sy, “Evaluation of Tc-99m-DMSA Renal Uptake as an Index of Individual Kidney Function after Acute Ureteral Obstruction and Desobstruction: An Experimental Study in Rats,” European Urology, Vol. 9, 1983, pp. 221-226.

[6]   I. A. Becker, R. Kutcher and N. Solomon, “The Radiology of Renal Failure,” In: E. A. Friedman, Ed., Strategy in Renal Failure, John Wiley and Sons, New York, 1978.

[7]   J. Bernheim, M. Collard, M. Westphall, A. Guey and J. Traeger, “Usefulness of Renal Scinitigraphic Scanning in the Prognosis of Acute Renal Failure (Author’s Transl),” Journal de Radiologie, d’électrologie, et de Médecine Nucléaire, Vol. 57, No. 1, 1976, pp. 63-68.

[8]   R. A. Sherman and M. D. Blaufox, “Obstructive Uropathy in Patients with Non-Visualization on Renal Scan,” Nephron, Vol. 25, No. 2, 1980, pp. 82-86.
http://dx.doi.org/10.1159/000181758

[9]   R. Romero, A. Caralps, A. Brulles, J. Andreu, J. Griño and J. Matin-Comin, “The Significance of the Absence of 131I-Hippuran Uptake by a Kidney Graft,” Nephron, Vol. 39, No. 4, 1985, pp. 306-308.
http://dx.doi.org/10.1159/000183395

[10]   F. G. Brivet, D. J. Kleinknecht, P. Loirat and P. J. Landais, “Acute Renal Failure in Intensive Care Units— Causes, Outcome, and Prognostic Factors of Hospital Mortality: A Prospective Multicenter Study,” Critical Care Medicine, Vol. 24, No. 2, 1996, pp. 192-198.
http://dx.doi.org/10.1097/00003246-199602000-00003

[11]   S. Uchino, J. A. Kellum, R. Bellomo, G. S. Doig, H. Morimatsu, S. Morgera, et al., “Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators. Acute Renal Failure in Critically ill Patients: A Multinational, Multicenter Study,” JAMA, Vol. 294, 2005, pp. 813-818.

[12]   R. W. Schrier and W. Wang, “Acute Renal Failure and Sepsis,” New England Journal of Medicine, Vol. 351, 2004, pp. 159-169.
http://dx.doi.org/10.1056/NEJMra032401

[13]   M. Oppert, C. Engel, F. M. Brunkhorst, H. Bogatsch, K. Reinhart, U. Frei, et al., “German Competence Network Sepsis (Sepnet). Acute Renal Failure in Patients with Severe Sepsis and Septic Shock—A Significant Independent Risk Factor for Mortality: Results from the German Prevalence Study,” Nephrology Dialysis Transplantation, Vol. 23, No. 3, 2008, pp. 904-909.
http://dx.doi.org/10.1093/ndt/gfm610

 
 
Top